THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS

<p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and over...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	A. O. Malygin [verfasserIn] V. L. Doshchitsin [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Russisch

Erschienen:	2015

Schlagwörter:	омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз

Übergeordnetes Werk:	In: Рациональная фармакотерапия в кардиологии - Столичная издательская компания, 2012, 9(2015), 1, Seite 56-61
Übergeordnetes Werk:	volume:9 ; year:2015 ; number:1 ; pages:56-61

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.1234/1819-6446-2013-1-56-61

Katalog-ID:	DOAJ053272625

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ053272625
003	DE-627
005	20230308173234.0
007	cr uuu---uuuuu
008	230227s2015 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1234/1819-6446-2013-1-56-61 \|2 doi
035			\|a (DE-627)DOAJ053272625
035			\|a (DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a rus
050		0	\|a RM1-950
050		0	\|a RC666-701
100	0		\|a A. O. Malygin \|e verfasserin \|4 aut
245	1	4	\|a THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
264		1	\|c 2015
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a <p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p<
650		4	\|a омега-3 полиненасыщенные жирные кислоты
650		4	\|a аритмии
650		4	\|a фибрилляция предсердий
650		4	\|a атеросклероз
653		0	\|a Therapeutics. Pharmacology
653		0	\|a Diseases of the circulatory (Cardiovascular) system
700	0		\|a V. L. Doshchitsin \|e verfasserin \|4 aut
773	0	8	\|i In \|t Рациональная фармакотерапия в кардиологии \|d Столичная издательская компания, 2012 \|g 9(2015), 1, Seite 56-61 \|w (DE-627)776633988 \|w (DE-600)2750390-2 \|x 22253653 \|7 nnns
773	1	8	\|g volume:9 \|g year:2015 \|g number:1 \|g pages:56-61
856	4	0	\|u https://doi.org/10.1234/1819-6446-2013-1-56-61 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61 \|z kostenfrei
856	4	0	\|u http://www.rpcardio.ru/jour/article/view/44 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1819-6446 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2225-3653 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 9 \|j 2015 \|e 1 \|h 56-61

Indexfelder

author_variant	a o m aom v l d vld
matchkey_str	article:22253653:2015----::huefmg3ataisoteramnoptetw
hierarchy_sort_str	2015
callnumber-subject-code	RM
publishDate	2015
allfields	10.1234/1819-6446-2013-1-56-61 doi (DE-627)DOAJ053272625 (DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61 DE-627 ger DE-627 rakwb eng rus RM1-950 RC666-701 A. O. Malygin verfasserin aut THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p< омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз Therapeutics. Pharmacology Diseases of the circulatory (Cardiovascular) system V. L. Doshchitsin verfasserin aut In Рациональная фармакотерапия в кардиологии Столичная издательская компания, 2012 9(2015), 1, Seite 56-61 (DE-627)776633988 (DE-600)2750390-2 22253653 nnns volume:9 year:2015 number:1 pages:56-61 https://doi.org/10.1234/1819-6446-2013-1-56-61 kostenfrei https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61 kostenfrei http://www.rpcardio.ru/jour/article/view/44 kostenfrei https://doaj.org/toc/1819-6446 Journal toc kostenfrei https://doaj.org/toc/2225-3653 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2015 1 56-61
spelling	10.1234/1819-6446-2013-1-56-61 doi (DE-627)DOAJ053272625 (DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61 DE-627 ger DE-627 rakwb eng rus RM1-950 RC666-701 A. O. Malygin verfasserin aut THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p< омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз Therapeutics. Pharmacology Diseases of the circulatory (Cardiovascular) system V. L. Doshchitsin verfasserin aut In Рациональная фармакотерапия в кардиологии Столичная издательская компания, 2012 9(2015), 1, Seite 56-61 (DE-627)776633988 (DE-600)2750390-2 22253653 nnns volume:9 year:2015 number:1 pages:56-61 https://doi.org/10.1234/1819-6446-2013-1-56-61 kostenfrei https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61 kostenfrei http://www.rpcardio.ru/jour/article/view/44 kostenfrei https://doaj.org/toc/1819-6446 Journal toc kostenfrei https://doaj.org/toc/2225-3653 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2015 1 56-61
allfields_unstemmed	10.1234/1819-6446-2013-1-56-61 doi (DE-627)DOAJ053272625 (DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61 DE-627 ger DE-627 rakwb eng rus RM1-950 RC666-701 A. O. Malygin verfasserin aut THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p< омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз Therapeutics. Pharmacology Diseases of the circulatory (Cardiovascular) system V. L. Doshchitsin verfasserin aut In Рациональная фармакотерапия в кардиологии Столичная издательская компания, 2012 9(2015), 1, Seite 56-61 (DE-627)776633988 (DE-600)2750390-2 22253653 nnns volume:9 year:2015 number:1 pages:56-61 https://doi.org/10.1234/1819-6446-2013-1-56-61 kostenfrei https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61 kostenfrei http://www.rpcardio.ru/jour/article/view/44 kostenfrei https://doaj.org/toc/1819-6446 Journal toc kostenfrei https://doaj.org/toc/2225-3653 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2015 1 56-61
allfieldsGer	10.1234/1819-6446-2013-1-56-61 doi (DE-627)DOAJ053272625 (DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61 DE-627 ger DE-627 rakwb eng rus RM1-950 RC666-701 A. O. Malygin verfasserin aut THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p< омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз Therapeutics. Pharmacology Diseases of the circulatory (Cardiovascular) system V. L. Doshchitsin verfasserin aut In Рациональная фармакотерапия в кардиологии Столичная издательская компания, 2012 9(2015), 1, Seite 56-61 (DE-627)776633988 (DE-600)2750390-2 22253653 nnns volume:9 year:2015 number:1 pages:56-61 https://doi.org/10.1234/1819-6446-2013-1-56-61 kostenfrei https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61 kostenfrei http://www.rpcardio.ru/jour/article/view/44 kostenfrei https://doaj.org/toc/1819-6446 Journal toc kostenfrei https://doaj.org/toc/2225-3653 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2015 1 56-61
allfieldsSound	10.1234/1819-6446-2013-1-56-61 doi (DE-627)DOAJ053272625 (DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61 DE-627 ger DE-627 rakwb eng rus RM1-950 RC666-701 A. O. Malygin verfasserin aut THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p< омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз Therapeutics. Pharmacology Diseases of the circulatory (Cardiovascular) system V. L. Doshchitsin verfasserin aut In Рациональная фармакотерапия в кардиологии Столичная издательская компания, 2012 9(2015), 1, Seite 56-61 (DE-627)776633988 (DE-600)2750390-2 22253653 nnns volume:9 year:2015 number:1 pages:56-61 https://doi.org/10.1234/1819-6446-2013-1-56-61 kostenfrei https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61 kostenfrei http://www.rpcardio.ru/jour/article/view/44 kostenfrei https://doaj.org/toc/1819-6446 Journal toc kostenfrei https://doaj.org/toc/2225-3653 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2015 1 56-61
language	English Russian
source	In Рациональная фармакотерапия в кардиологии 9(2015), 1, Seite 56-61 volume:9 year:2015 number:1 pages:56-61
sourceStr	In Рациональная фармакотерапия в кардиологии 9(2015), 1, Seite 56-61 volume:9 year:2015 number:1 pages:56-61
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз Therapeutics. Pharmacology Diseases of the circulatory (Cardiovascular) system
isfreeaccess_bool	true
container_title	Рациональная фармакотерапия в кардиологии
authorswithroles_txt_mv	A. O. Malygin @@aut@@ V. L. Doshchitsin @@aut@@
publishDateDaySort_date	2015-01-01T00:00:00Z
hierarchy_top_id	776633988
id	DOAJ053272625
language_de	englisch russisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ053272625</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308173234.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1234/1819-6446-2013-1-56-61</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ053272625</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC666-701</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">A. O. Malygin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">омега-3 полиненасыщенные жирные кислоты</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">аритмии</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фибрилляция предсердий</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">атеросклероз</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the circulatory (Cardiovascular) system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. L. Doshchitsin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Рациональная фармакотерапия в кардиологии</subfield><subfield code="d">Столичная издательская компания, 2012</subfield><subfield code="g">9(2015), 1, Seite 56-61</subfield><subfield code="w">(DE-627)776633988</subfield><subfield code="w">(DE-600)2750390-2</subfield><subfield code="x">22253653</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:56-61</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1234/1819-6446-2013-1-56-61</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.rpcardio.ru/jour/article/view/44</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1819-6446</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2225-3653</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="h">56-61</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	A. O. Malygin
spellingShingle	A. O. Malygin misc RM1-950 misc RC666-701 misc омега-3 полиненасыщенные жирные кислоты misc аритмии misc фибрилляция предсердий misc атеросклероз misc Therapeutics. Pharmacology misc Diseases of the circulatory (Cardiovascular) system THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
authorStr	A. O. Malygin
ppnlink_with_tag_str_mv	@@773@@(DE-627)776633988
format	electronic Article
delete_txt_mv	keep
author_role	aut aut
collection	DOAJ
remote_str	true
callnumber-label	RM1-950
illustrated	Not Illustrated
issn	22253653
topic_title	RM1-950 RC666-701 THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS омега-3 полиненасыщенные жирные кислоты аритмии фибрилляция предсердий атеросклероз
topic	misc RM1-950 misc RC666-701 misc омега-3 полиненасыщенные жирные кислоты misc аритмии misc фибрилляция предсердий misc атеросклероз misc Therapeutics. Pharmacology misc Diseases of the circulatory (Cardiovascular) system
topic_unstemmed	misc RM1-950 misc RC666-701 misc омега-3 полиненасыщенные жирные кислоты misc аритмии misc фибрилляция предсердий misc атеросклероз misc Therapeutics. Pharmacology misc Diseases of the circulatory (Cardiovascular) system
topic_browse	misc RM1-950 misc RC666-701 misc омега-3 полиненасыщенные жирные кислоты misc аритмии misc фибрилляция предсердий misc атеросклероз misc Therapeutics. Pharmacology misc Diseases of the circulatory (Cardiovascular) system
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Рациональная фармакотерапия в кардиологии
hierarchy_parent_id	776633988
hierarchy_top_title	Рациональная фармакотерапия в кардиологии
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)776633988 (DE-600)2750390-2
title	THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
ctrlnum	(DE-627)DOAJ053272625 (DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61
title_full	THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
author_sort	A. O. Malygin
journal	Рациональная фармакотерапия в кардиологии
journalStr	Рациональная фармакотерапия в кардиологии
callnumber-first-code	R
lang_code	eng rus
isOA_bool	true
recordtype	marc
publishDateSort	2015
contenttype_str_mv	txt
container_start_page	56
author_browse	A. O. Malygin V. L. Doshchitsin
container_volume	9
class	RM1-950 RC666-701
format_se	Elektronische Aufsätze
author-letter	A. O. Malygin
doi_str_mv	10.1234/1819-6446-2013-1-56-61
author2-role	verfasserin
title_sort	use of omega-3 fatty acids for the treatment of patients with cardiac arrhythmias
callnumber	RM1-950
title_auth	THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
abstract	<p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p<
abstractGer	<p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p<
abstract_unstemmed	<p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p<
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	1
title_short	THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
url	https://doi.org/10.1234/1819-6446-2013-1-56-61 https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61 http://www.rpcardio.ru/jour/article/view/44 https://doaj.org/toc/1819-6446 https://doaj.org/toc/2225-3653
remote_bool	true
author2	V. L. Doshchitsin
author2Str	V. L. Doshchitsin
ppnlink	776633988
callnumber-subject	RM - Therapeutics and Pharmacology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1234/1819-6446-2013-1-56-61
callnumber-a	RM1-950
up_date	2024-07-03T16:46:26.219Z
_version_	1803577129665822720
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ053272625</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308173234.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1234/1819-6446-2013-1-56-61</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ053272625</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ00a3ddf0bedc46beb8c33d90d2e81e61</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC666-701</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">A. O. Malygin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">омега-3 полиненасыщенные жирные кислоты</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">аритмии</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фибрилляция предсердий</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">атеросклероз</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the circulatory (Cardiovascular) system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. L. Doshchitsin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Рациональная фармакотерапия в кардиологии</subfield><subfield code="d">Столичная издательская компания, 2012</subfield><subfield code="g">9(2015), 1, Seite 56-61</subfield><subfield code="w">(DE-627)776633988</subfield><subfield code="w">(DE-600)2750390-2</subfield><subfield code="x">22253653</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:56-61</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1234/1819-6446-2013-1-56-61</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/00a3ddf0bedc46beb8c33d90d2e81e61</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.rpcardio.ru/jour/article/view/44</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1819-6446</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2225-3653</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="h">56-61</subfield></datafield></record></collection>
score	7.401602

Nicht das Richtige dabei?

Schreiben Sie uns!

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?